Company intelligence / Profile preview

Sorrel Medical

Netanya, Israel

Ownership: Private
Development stage: Other

Overview

Sorrel Medical develops and manufactures platform-based, prefilled, fully disposable wearable injectors (1–20/25 mL) for subcutaneous delivery of large-volume and high-viscosity drugs, with integrated smart sensing, connectivity (Bluetooth/NFC), and UV-LED point-of-care disinfection; devices are used in clinical trials and commercial combination products with multiple pharma partners, but clinical outcomes belong to partners’ drugs rather than Sorrel itself.[1][2][4][5][6]

Modalities: DeviceBiologicSmall moleculeNanoparticlePeptidesProtein
Industry: Therapeutic Medical Devices

Partnerships

Multiple unnamed global pharmaceutical manufacturers developing wearable drug–device combination products using Sorrel’s platform[2][4][5][6]

Beyond the preview

Go deeper on Sorrel Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorrel Medical.

Explore the full profile